NB
NGM Bio Holdings, Inc.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$142Msold at filing
Total offering$142M
Investors in the raise26count reported to the SEC
FiledMar 27, 2026first sale Jul 5, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Diana Peng BockusExecutive Officer, Director
Tim Peng KutzkeyDirector
Roger M. PerlmutterDirector
Peter M. SvennilsonDirector
Executive officers, directors and promoters as listed on the Form D.